Company Quick10K Filing
Nemus Bioscience
10-Q 2020-09-30 Filed 2020-11-06
S-1 2020-07-13 Public Filing
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-03-23
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-09
S-1 2019-06-04 Public Filing
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-03-14
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-10
10-Q 2018-03-31 Filed 2018-05-15
S-1 2018-03-23 Public Filing
10-K 2017-12-31 Filed 2018-03-19
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-10
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-21
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-09-15
10-Q 2014-04-30 Filed 2014-06-05
10-Q 2014-01-31 Filed 2014-03-17
10-K 2013-10-31 Filed 2014-01-27
10-Q 2013-07-31 Filed 2013-09-16
10-Q 2013-04-30 Filed 2013-06-27
8-K 2020-09-25
8-K 2020-08-07
8-K 2020-07-31
8-K 2020-06-17
8-K 2020-04-29
8-K 2019-12-17
8-K 2019-11-21
8-K 2019-11-19
8-K 2019-08-23
8-K 2019-08-21
8-K 2019-08-07
8-K 2019-05-24
8-K 2019-03-29
8-K 2019-03-25
8-K 2019-02-26
8-K 2019-02-01
8-K 2018-11-14
8-K 2018-11-01
8-K 2018-10-05
8-K 2018-07-31
8-K 2018-06-01
8-K 2018-04-30
8-K 2018-02-16
8-K 2018-02-13
8-K 2018-01-19
8-K 2017-12-28

Nemus Bioscience Financials

NMUS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2013-04-302013-07-312013-10-312014-01-312014-04-302014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3037524650391,0252071776014,3433,2212,06283232065380109422602,9501,8791,0631,8584,4172,8121,324
Accounts Receivable322925353527
Inventory
PP&E6947474747961221191716132117131075312543332
Assets1341291461411231681,1263484698214,5423,5112,3501,0816923236174843435573,1582,0421,1661,9574,7253,0801,725
Accounts Payable4093882861321251371833872752276799901019912461616873207
Long-Term Debt43
Liabilities6964625449863508028071,6823,5153,0403,3601,3371,7111,7741,8472,2622,4481,3578,91210,28811,32117,51932,58914,72118,127
Stockholders' Equity666583877381776-454-338-861-594-892-2,370-1,615-2,379-2,914-2,879-2,927-3,230-3,570-5,754-8,245-10,155-15,562-27,864-11,641-16,402
Income Statement ($'000)2013-04-302013-07-312013-10-312014-01-312014-04-302014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D195323743152343135460812639261897025-6467321688513
SG&A45169796634668731,3137448111,0851,0227766491,2886706739171,2261,0809781,1941,083990
Tax1-1-0010131000000022-2020020
Net Income2-1-54-148-859-2,732-910-2,057-1,183-691-1,685573-945-1,120-1,283-703-480-628-8,214-2,662-2,096-14,77415,905-4,931
Cash Flow ($'000)2013-04-302013-07-312013-10-312014-01-312014-04-302014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating7-8-438-952-1,762-752-568-1,295-1,114-1,148-1,230-512-663-816-271-67-2,144-1,053-816-1,431-1,605-1,488
Cash Investing5224500-20-1100-10
Cash Financing-41-20491,9911,9387219925,038-84081,132002,3813,74003,99100